AVEO Pharmaceuticals (AVEO) Plans Stock Offering
Tweet
Share
E-mailGet Alerts AVEO Hot Sheet
Join SI Premium – FREE
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares in the offering are to be sold by AVEO.
The proposed size of the offering was note disclosed.
J.P. Morgan Securities LLC is acting as sole book-running manager for the proposed offering, with RBC Capital Markets, LLC and Canaccord Genuity Inc. acting as co-lead managers.
The proposed size of the offering was note disclosed.
J.P. Morgan Securities LLC is acting as sole book-running manager for the proposed offering, with RBC Capital Markets, LLC and Canaccord Genuity Inc. acting as co-lead managers.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Therapeutics prices $500M stock and convertible notes offering
- Oura seeks to raise up to $2.2 billion in Nasdaq IPO
- Live Oak Acquisition Corp. VI prices $200M IPO on Nasdaq
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
JPMorgan, RBC Capital, Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
